ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 8 SUPPL., 2004, Pages

  Suzuki, Yoshihiko ^a,b,e,f   Taniyama, Matsuo ^b   Muramatsu, Tara ^c   Higuchi, Susumu ^d   Ohta, Shigeo ^e   Atsumi, Yoshihito ^a   Matsuoka, Kempei ^a  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d KURIHAMA NATIONAL HOSPITAL   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f Hoken Dohjin Medical Foundation   (Japan)

Author keywords

Alcohol Dehydrogenase 2; Aldehyde Dehydrogenase 2; Diabetic Neuropathy; Diabetic Vasculopathy; Type 2 Diabetes

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL DEHYDROGENASE; ALDEHYDE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; PROTEIN KINASE C; ADH1B PROTEIN, HUMAN; ALDEHYDE DEHYDROGENASE; ALDH2 PROTEIN, HUMAN;

CONFERENCE PAPER; CONTROLLED STUDY; DETOXIFICATION; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME ASSAY; GENETIC REGULATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; PROTEINURIA; SENSORY NERVE CELL; ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIABETIC RETINOPATHY; FEMALE; GENETIC POLYMORPHISM; GENETICS; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 16644368086     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1097/01.ALC.0000133583.44581.99     Document Type: Conference Paper

References (25)

1. Barnett AH, Leslie RDG, Pyke DA (1981) Chlorpropamide-alcohol flushing and proteinuria in non-insulin-dependent diabetics. BMJ 282:522-523.
2. Chiarpotto E, Domenicotti C, Paola D, Vitali A, Nitti M, Pronzato MA, Biasi F, Cottalasso D, Marinari UM, Dragonetti A, Cesaro P, Isidoro C, Poli G (1999) Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 29:1565-1572.
3. Corso AD, Monte MD, Vilardo PG, Gecconi I, Moschini R, Banditelli S, Cappiello M, Tsai L, Mura U (1998) Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch Biochem Biophys 350: 245-248.
4. Crabb DW, Edenberg HJ, Bosron WF, Li TK (1989) Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity: the inactive ALDH22 allele is dominant. J Clin Invest 83:314-316.
5. Desilva NE, Tunbridge WMG, Alberti KGMM (1981) Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin-independent diabetes. Lancet 1:128-131.
6. Esterbauer H, Zolliner H, Lang J (1985) Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem J 228:363-373.
7. Hartly DP, Petersen DR (1997) Co-metabolism of ethanol, ethanol-derived acetaldehyde, and 4-hydroxynonenal in isolated rat hepatocytes. Alcohol Clin Exp Res 21:298-304.
8. Kobberling J, Bengsch N, Bruggehoes B (1980) The chlorpropamide alcohol flush. Diabetologia 19:359-363.
9. Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866.
10. Leslie RDG, Pyke DA (1979) Chlorpropamide alcohol flushing and diabetic retinopathy. Lancet 12:997-999.
11. Low PA, Nickander KK, Tritschler HJ (1997) The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 Suppl 2:538-42.
12. Muramatsu T, Wang Zu-Cheng, Fang Yi-Ru, Hu B, Van H, Yamada K, Higuchi S, Harada S, Kono H (1995) Alcohol and aldehyde dehydrogenase genotypes and drinking behavior of Chinese living in Shanghai. Hum Genet 96:151-154.
13. 1-alkyl- substituted derivatives of chlorpropamide as inhibitors of aldehyde dehydrogenase. J Med Chem 32:1335-1340.
14. Ohsawa I, Nishimaki K, Yasuda C, Kamino K, Ohta S (2003) Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J Neurochem 84:1110-1117.
15. Picklo MJ, Olson SJ, Markesbery WR, Montine TJ (2001) Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol 60: 686-95.
16. Pyke DA (1979) Diabetes: the genetic connections. Diabetologia 17:333-343.
17. Pyke DA, Leslie RDG (1978) Chlorpropamide-alcohol flushing: a definition of its relation to non-insulin-dependent diabetes. BMJ 2:1521-1522.
18. Schmeichel AM, Schmelzer JD, and Low PA (2003) Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52: 165-171.
19. +-ATPase. Free Radie Biol Med 20: 215-223.
20. Spycher S, Tabataba-Vakili S, O'Donnell VB, Palomba L, Azzi A (1996) 4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem Biophys Res Comm 226: 512-516.
21. Leu(UUR) mutation at position 3243. Diabetes Care 12:1423-1425.
22. Suzuki Y, Taniyama M, Muramatsu T, Higuchi S, Ohta S, Atsumi Y, Matsuoka K (2003) Diabetic vasculopathy and alcohol tolerance trait in type 2 diabetes. Diabetes Care 26:246-247.
23. Tattersal RB, Fajans SS (1975) A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 24:44-53.
24. Vander Jagt DL, Kolb NS, Vander Jagt TJ, Chino J, Martinez FJ, Hunsaker LA, Royer RE (1995) Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta 249: 117-126.
25. Xu Y, Carr LG, Bosron WF, Li TK, Edenberg HJ (1998) Genotyping of human alcohol dehydrogenase at the ADH2 and ADH2 loci following DNA sequence amplification. Genomics 2:209-214.